Aldeyra Therapeutics, Inc. - ALDX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 13
Latest filed: Apr 20, 2026
| Form | Count |
|---|---|
| 8-K | 7 |
| 4 | 3 |
| SCHEDULE 13G/A | 3 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 20, 2026 | 8-K | Apr 20, 2026 | 0001193125-26-164198 | View |
| Apr 01, 2026 | 8-K | Apr 01, 2026 | 0001193125-26-137984 | View |
| Mar 31, 2026 | 4 | Mar 27, 2026 | 0001193125-26-134631 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | — | 0000102909-26-000589 | View |
| Mar 20, 2026 | 4 | Mar 19, 2026 | 0001193125-26-117675 | View |
| Mar 19, 2026 | 4 | Mar 18, 2026 | 0001193125-26-116247 | View |
| Mar 17, 2026 | 8-K | Mar 17, 2026 | 0001193125-26-109511 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001193125-26-054525 | View |
| Dec 31, 2025 | 8-K | Dec 23, 2025 | 0001193125-25-338394 | View |
| Dec 16, 2025 | 8-K | Dec 15, 2025 | 0001193125-25-319638 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0001193125-25-282830 | View |
| Nov 13, 2025 | 8-K | Nov 13, 2025 | 0001193125-25-278804 | View |
| Oct 28, 2025 | 8-K | Oct 28, 2025 | 0001193125-25-252200 | View |